• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用嗜丙酸杆菌KP - 40对急性实验性感染猪进行预防性应用。I. 病毒感染——奥耶斯基氏病和经典猪瘟。

Prophylactic application of Propionibacterium avidum KP-40 in swine with acute experimental infections. I. Viral infections--Aujeszky's disease and classical swine fever.

作者信息

Markowska-Daniel I, Pejsak Z, Szmigielski S, Jeljaszewicz J, Pulverer G

机构信息

Department of Swine Diseases, National Institute of Veterinary Research, Pulawy, Poland.

出版信息

Dtsch Tierarztl Wochenschr. 1993 Apr;100(4):149-51.

PMID:8486091
Abstract

The usefulness of the prophylactic application of Propionibacterium avidum KP-40 (PA), a potent stimulator of the macrophage-monocyte system and inducer of endogenous interferons, was demonstrated in swine infected experimentally with Aujeszky's disease or classical swine fever viruses. Some of the infected animals were preimmunized with respective vaccines containing live, attenuated viruses. In vaccinated and non-vaccinated swine infected with Aujeszky's disease virus, pretreatment with PA lowered the morbidity rate, shortened the period of fever and fastened the recovery. Infection with classical swine fever virus resulted in 100% mortality of PA-pretreated non-vaccinated swine, but the length survival of the animals was significantly longer (p < 0.05).

摘要

在实验感染奥耶斯基氏病病毒或经典猪瘟病毒的猪身上,证明了痤疮丙酸杆菌KP-40(PA)(一种巨噬细胞-单核细胞系统的强效刺激剂和内源性干扰素诱导剂)预防性应用的有效性。一些感染动物用含有活的减毒病毒的相应疫苗进行了预免疫。在用奥耶斯基氏病病毒感染的接种和未接种疫苗的猪中,PA预处理降低了发病率,缩短了发热期并加速了康复。经典猪瘟病毒感染导致PA预处理的未接种疫苗的猪100%死亡,但动物的存活时间明显更长(p<0.05)。

相似文献

1
Prophylactic application of Propionibacterium avidum KP-40 in swine with acute experimental infections. I. Viral infections--Aujeszky's disease and classical swine fever.用嗜丙酸杆菌KP - 40对急性实验性感染猪进行预防性应用。I. 病毒感染——奥耶斯基氏病和经典猪瘟。
Dtsch Tierarztl Wochenschr. 1993 Apr;100(4):149-51.
2
Prophylactic application of Propionibacterium avidum KP-40 in swine with acute experimental infections. II. Bacterial infections: pleuropneumonia and swine erysipelas.嗜丙酸杆菌KP-40在急性实验性感染猪中的预防性应用。II. 细菌感染:胸膜肺炎和猪丹毒。
Dtsch Tierarztl Wochenschr. 1993 May;100(5):185-8.
3
Adjuvant properties of propionibacterium avidum KP-40 in vaccination against endemic viral and bacterial infections. I. Swine immunized with live attenuated Aujeszky's disease virus vaccine and experimentally infected with virulent viruses.嗜丙酸杆菌KP-40在预防地方性病毒和细菌感染疫苗接种中的佐剂特性。I. 用减毒活A型疱疹病毒疫苗免疫并经强毒病毒实验感染的猪。
Zentralbl Bakteriol. 1992 Dec;277(4):529-37. doi: 10.1016/s0934-8840(11)80478-0.
4
[Associated vaccination of pigs against swine fever, erysipelas and Aujeszky's disease].
Vet Med Nauki. 1986;23(3):9-13.
5
[Aerogenic simultaneous vaccination of swine against plague, erysipelas and Aujeszky's disease].
Veterinariia. 1976 Nov(11):42-4.
6
[Simultaneous immunization of suckling pigs against plague, Aujeszky's disease and erysipelas].
Veterinariia. 1975 Feb(2):57-9.
7
Combined vaccination against infectious diseases of pigs. II. Simultaneous vaccination against Aujeszky's disease and swine erysipelas with live vaccines.
Bull Off Int Epizoot. 1967 Mar-Apr;67(3):577-95.
8
[A field test of an associated vaccine for swine plague and Aujeszky's disease].
Veterinariia. 1967 May;44(5):49-50.
9
Prophylactic and therapeutic application of Propionibacterium avidum KP-40 in swine and calves with acute enzootic bronchopneumonia.
Dtsch Tierarztl Wochenschr. 1991 Oct;98(10):384-7.
10
[Simultaneous vaccination against Aujeszky's disease and European hog cholera].
Berl Munch Tierarztl Wochenschr. 1985 Apr 1;98(4):109-12.

引用本文的文献

1
Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium) , an Underrecognized Microorganism.临床和生物学特征的痤疮丙酸杆菌(原丙酸杆菌属),一个认识不足的微生物。
Clin Microbiol Rev. 2018 May 30;31(3). doi: 10.1128/CMR.00064-17. Print 2018 Jul.